JASON MELTON: Open Payments
NPI 1467525865 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 32 payments from 12 companies in 2025. Trend: 2023 $398 · 2024 $845 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $138 |
| Sumitomo Pharma America, Inc. | 5 | $104 |
| Janssen Biotech, Inc. | 4 | $103 |
| Dendreon Pharmaceuticals LLC | 3 | $70 |
| PFIZER INC. | 3 | $48 |
| Teleflex LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Olympus America Inc. | 1 | $25 |
| COLOPLAST CORP | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: INTERSTIM, ERLEADA, PROVENGE, GEMTESA, XTANDI, UROLIFT, PLUVICTO, ORGOVYX.
Industry payments across MS — which companies pay providers there.
